PhRMA sues HHS over drug price negotiation; how ‘tranq’ is making opioid overdoses harder to reverse

The pharmaceutical industry's biggest lobbying group, PhRMA, filed a lawsuit challenging Democrats' drug pricing law.

June 21, 2023 Check out STAT+

Sponsored By

Graeme Sloan/Sipa USA STAT+ | PhRMA sues Biden administration over Medicare drug price negotiation program The pharmaceutical industry's biggest lobbying group filed a lawsuit challenging Democrats' Medicare drug pricing law. By Rachel Cohrs Xylazine, or 'tranq,' is making opioid overdoses harder to reverse Tranq-laced opioids mean that the go-to remedy for overdose, naloxone, needs to be supplemented with oxygen. By Lev Facher STAT+ | After promising early data, gene therapy trial for Huntington's takes puzzling turn Uniqure's gene therapy for Huntington's disease offers promising but difficult to interpret data for the neurodegenerative condition. By Jason Mast Caroline Yang for STAT Scientists successfully unfroze rat organs and transplanted them — a 'historic' step that could someday transform transplant medicine In 'historic' first, scientists freeze, thaw, and transplant rat organs — bringing transplant medicine one step closer to stopping time. By Marion Renault Sen. Grassley calls on GOP leaders to rally support for PBM reforms Republican Sen. Chuck Grassley wants to see his party's leadership turn up the pressure on pharmacy benefit managers. By Sarah Owermohle Amid the AI gold rush, a new company forms to vet models and root out weaknesses The market for artificial intelligence in health care is about as transparent as a brick wall. Dandelion Health is promising to change that. By Casey Ross Alastair Grant/AP Opinion: Pregnancy-related death, like Tori Bowie's, is a far too common occurrence among Black women Rather than talk about racism, people want to blame Black maternal mortality rates on the social determinants of health. That's a cop-out. By Omare Jimmerson New DNA test aims to make cervical cancer screening more accessible in low-income countries A new study suggests an HPV DNA test could make cervical cancer screening more accessible to women in developing countries. By Abdullahi Tsanni

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser